Category 3 - THERAPEUTIC PROCEDURES
16018 - Additional Information
Item Start Date:
01-May-2000
Description Updated:
01-Jul-2008
Schedule Fee Updated:
01-Jul-2022
Group
T3 - Therapeutic Nuclear Medicine
ADMINISTRATION OF 153 SM-LEXIDRONAM for the relief of bone pain due to skeletal metastases (as indicated by a positive bone scan) where hormonal therapy and/or chemotherapy have failed and either the disease is poorly controlled by conventional radiotherapy or conventional radiotherapy is inappropriate, due to the wide distribution of sites of bone pain.
Fee: $2,582.05 Benefit: 75% = $1,936.55 85% = $2,488.85
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change